key: cord-0196445-k3w705ft
authors: Nelson, Amy PK; Gray, Robert J; Ruffle, James K; Watkins, Henry C; Herron, Daniel; Sorros, Nick; Mikhailov, Danil; Cardoso, M. Jorge; Ourselin, Sebastien; McNally, Nick; Williams, Bryan; Rees, Geraint E.; Nachev, Parashkev
title: Deep forecasting of translational impact in medical research
date: 2021-10-17
journal: nan
DOI: nan
sha: 2ff7fb77454f3d2a3e3917291170a711490198eb
doc_id: 196445
cord_uid: k3w705ft

The value of biomedical research--a $1.7 trillion annual investment--is ultimately determined by its downstream, real-world impact. Current objective predictors of impact rest on proxy, reductive metrics of dissemination, such as paper citation rates, whose relation to real-world translation remains unquantified. Here we sought to determine the comparative predictability of future real-world translation--as indexed by inclusion in patents, guidelines or policy documents--from complex models of the abstract-level content of biomedical publications versus citations and publication meta-data alone. We develop a suite of representational and discriminative mathematical models of multi-scale publication data, quantifying predictive performance out-of-sample, ahead-of-time, across major biomedical domains, using the entire corpus of biomedical research captured by Microsoft Academic Graph from 1990 to 2019, encompassing 43.3 million papers across all domains. We show that citations are only moderately predictive of translational impact as judged by inclusion in patents, guidelines, or policy documents. By contrast, high-dimensional models of publication titles, abstracts and metadata exhibit high fidelity (AUROC>0.9), generalise across time and thematic domain, and transfer to the task of recognising papers of Nobel Laureates. The translational impact of a paper indexed by inclusion in patents, guidelines, or policy documents can be predicted--out-of-sample and ahead-of-time--with substantially higher fidelity from complex models of its abstract-level content than from models of publication meta-data or citation metrics. We argue that content-based models of impact are superior in performance to conventional, citation-based measures, and sustain a stronger evidence-based claim to the objective measurement of translational potential.

Scientometrics has existed for only a small fraction of the history of science itself, sparked by the logical empiricists of the Vienna Circle in their philosophical quest to construct a unified language of science (1) .

Developed into the familiar, citation-centred form through arduous manual extraction by Garfield and Price in the mid-20th century (2, 3) , its indicators have proliferated in the Internet age. They now dominate the research landscape, routinely informing major funding decisions and academic staff recruitment worldwide (4) (5) (6) (7) (8) .

The importance of the original goal has become magnified over time: to measure scientific progress regardless of funding or ideology, uncoloured by the reputations of individuals or institutions. But the fundamental focus of its current solution-the volume and density of discussion in print-is both detached from the ultimate, real-world objective, and subject to familiar distortions such as the popularity of papers notable only for being spectacularly wrong (9) (10) (11) .

These concerns are amplified in medical science, whose primary focus is not merely knowledge, but impact on patient health: necessarily a consequence rather than a constitutive characteristic of research activity, neither easily benchmarked nor directly optimised. And there is no doubt that optimisation is needed: over the past 60 years, the number of new drug approvals per unit R&D spend has consistently halved every nine years while published medical research has doubled with the same periodicity (12) , and only 0.004% of basic research findings ultimately lead to clinically useful treatments (13) . The critical pre-requisite for all research-funding-shows substantial randomness in its distribution (14) , enough for at least one major healthcare funder to award grants by lottery (15) . Any decision function based on random chance, or a process demonstrably not much better than random chance, leaves room for improvement, particularly when commanding approximately $1.7 trillion global annual investment across the US, Japan, South Korea and the European Union (16) .

Is this state of affairs partially caused by over-reliance on misleading scientometrics, have we simply not found the right metrics yet, or is the relation between scientific activity and consequent impact opaque to objective analysis? To address these crucial questions, we need a fully-inclusive survey of published medical research that relates its characteristics to an independently measured translational outcome as close to realworld impact as can be quantified. This relationship must be explored with models of sufficient expressivity to detect complex relations between many candidate predictive factors beyond paper-to-paper citations.

Here we provide the first comprehensive, field-wide analysis of translational impact measured by its most widely accepted proximal indices-patents, guidelines or policies-based on 30 years of data from the medical field. We quantify the ability to predict inclusion in future patents, guidelines or policies from conventional age-normalised citation counts, and compare this with the predictive fidelity of deep learning models incorporating more complex features extracted from metadata, titles and abstracts. The breadth and depth of analysis allows us to draw strong conclusions about the application of metrics to translational forecasting with substantial implications for research policy.

Over the period from January 1990 to March 2019, only 17.1 million of the 43.3 million published papers categorised as medical by Microsoft Academic Graph were cited at least once. Of these, 964403 were included in a patent, and 16752 in a guideline or a policy document. Included papers were more frequently cited, but the numbers of citations and inclusions were weakly correlated (Pearson's r = 0.094 for guidelines or policies, r = 0.248 for patents, fig. 1 ).

Attempting to predict inclusion in a guideline or policy document from the traditional measure of impactannual paper citations-yielded a mean cross-validated AUROC of 0.77 with univariable logistic regression. By contrast, a high-dimensional model trained on metadata, and title and abstract embeddings, based on a hybrid multilayer perceptron (MLP) and convolutional neural network (CNN), achieved an area under the receiver operating curve (AUROC) of 0.915 and average precision (AP) of 0.919 on unseen test data ( fig. 2A, fig.  S1 ). The MLP trained on only metadata, without title or abstract embeddings, achieved a lower mean crossvalidated AUROC of 0.88, significantly so as judged by cross-validation confidence intervals.

For the task of predicting patent inclusions, univariable logistic regression on annual paper citations yielded a mean cross-validated AUROC of 0.756. A high-dimensional model trained on metadata, and title and abstract embeddings, achieved much higher AUROC of 0.918 and AP of 0.859 on unseen test data, fig. 2B . The MLP trained on only metadata, without title or abstract embeddings, achieved a lower mean cross-validated AUROC of 0.876.

Across both tasks, a high-dimensional neural network model trained on both metadata and content embeddings substantially outperforms more commonly used paper citation based metrics when predicting future translational impact.

To test the generalisability of the models, we must examine sustained performance over time and across Performance under metadata restriction Rebuilding the foregoing models without paper-level metrics-paper citations, paper rank and paper mentions-and more stringently, also without attributes influenced by factors of merit extrinsic to the paper itself-affiliation, authors, journal and field-yielded slightly diminished fidelity. For guideline and policy inclusions, the combined content and metadata without paper-level metrics achieved AUROCs of 0.91, 

If the high-dimensional models are capable of capturing fundamental features of translational impact, they may identify papers whose impact is judged by other criteria. To test for such transfer learning we applied our best patent model-without retraining to new targets-to the task of identifying the papers of Nobel prizewinners in Physiology or Medicine from 1991 to 2019 published before the prize was awarded. There were 166 such papers with abstracts in MAG, of which 60 were included in patents. Strikingly, the best model retrieved a higher proportion of Nobel laureate papers (103/166) than metadata (86/166) or age-normalised citations 

A complex, high-dimensional model cannot easily yield intelligible weightings of predictive importance because its decision is a highly non-linear function of a large set of input features. A coarse indication of relative feature importance can nonetheless be derived from alternative architectures of lesser flexibility.

Here a boosted trees (AdaBoost) model was used, trained on the metadata and optimised by gridsearch to similar performance as the MLP (AUROC 0.88, guideline or policy inclusions; AUROC 0.877, patent inclusions) (table S1).

For guideline or policy inclusions, the rank of the paper-a metric provided by Microsoft Academic Graph (MAG)(17) reflecting the eigencentrality-based 'influence' of a paper-had the highest feature importance, followed by the paper count, citation count and rank of the journal in which the paper was published. For patent inclusions, the top three features were related to journal productivity-related metrics.

Deep semantic structure of titles and abstracts 

The similarity and dissimilarity between papers can be modelled as a graph whose edges index the dependencies between individual features. Hierarchically arranged distinct patterns of similarity-the graph's community structure-can then be revealed by stochastic block modelling (19) , here performed separately for guideline or policy-included papers, and patent-included papers, each compared against all other papers. Table 1A . This corresponds to a medical domain 'impact factor' over three decades, rather than the commonly reported annual. The equivalent ranking for guideline and patent inclusions, identically filtered, are listed in Tables 1B and 1C respectively. Note that in the absence of plausibly objective weighting of policies or guidelines, this metric will be sensitive to the numerosity of distinct policy documents within any given domain, reflecting its political, regulatory, or administrative complexity.

We provide the first comprehensive framework for forecasting the translation of published medical research in the form of patent, guideline or policy inclusions, revealing the community structure of translational inclusions, and compute the top translationally relevant journals across biomedicine over the past 30 years.

We show that standard citation metrics are markedly inferior to those derived from complex models based on more detailed descriptions of published research. If objective metrics are to be used in translational assessment, then the use of conventional metrics is here shown to be insupportable.

Our analysis suggests the problem rests not with citations, but with the expressivity of any simple metric of something as constitutionally complex as research translation. It is clear that the translational signal is distributed through the combinatorial fabric of paper citation networks, metadata, and content captured in titles and abstracts. No easily interpretable scalar value could capture it. Conversely, that surprisingly economical information about a paper-its metadata, title and abstract-can be exploited by the right modelling architecture to yield high predictive fidelity, means no one could argue that no objective alternative is available. Even without full text information, we can confidently identify large swathes of research activity unlikely to inform guidelines or policy, or to become the substrate of patents, across time and diverse subdomains. The choice now is not between subjective, qualitative assessment and simple quantitative metrics, but with machine learning models no less objective, reproducible, and generalisable for being complex. We cannot and do not argue that machine learning models remove the need for qualitative assessment, but only that the quantitative metrics in current use could be far better. Indeed, the clearly observed relation between model complexity and achieved fidelity suggests modelling of the body of a paper-currently infeasible for copyright reasons-is likely to yield still higher fidelity. This will inevitably usher an examination of policies on the right trade-off between performance and intelligibility that must be settled politically, not empirically.

Our models are of direct, first-order inclusions, indifferent to the upstream published sources a given paper itself cites. They may be more likely to predict the translational potential of a meta-analysis, for example, than that of any of the preceding studies informing it. But the proposed framework can be naturally extended to second or higher order inclusions earlier in the citation path, weighting the cascade of information down the full translational pathway in a principled way. For example, the citation nexus has been modelled as a graph (20) with publication-based metrics as the predictive target, in evolution of established approaches for predictive modelling of bibliographically defined impact (21, 22) . Note the constraint on inclusion depth amongst other considerations prevents the naïve use of our models to determine the causal sufficiency of translation, but no-one would claim that any metric within so complex a system could plausibly index causality on its own. A complex model can also be used to distinguish empirical from meta-analytical papers with potentially greater accuracy than bibliographic "article type" tags, weighting inclusions their empirical content.

Equally, while unethical biases can corrupt carelessly designed or interpreted complex models, they can also be revealed by them where the neglected subpopulation is defined by the complex interaction of several variables of ethical concern simple models are too crude to illuminate. Insisting on simple, low-dimensional decision boundaries does not remove bias but merely conceals it from view: complex models-correctly designed and used-are not the problem here but an essential part of the solution. A sharp distinction must be drawn between simplicity and explainability: where a system is inherently, irreducibly complex, a simple metric cannot be explanatory. The unprecedented scale of analysed data, drawn from the largest open bibliographic repository in the world, limits potential distortion from sampling bias; the use of out-of-sample, ahead-of-time measures of performance further strengthens generalisability. Any individual or institution can submit test data to the model, and independently validate predictions over time, or retrain with further, prospectively acquired data.

Our work builds on existing research on patent, guideline and policy inclusions. A "patent-paper citation index" has been proposed to formalise science-to-technology linkages (23) , and patent inclusions have been systematically evaluated to quantify value return on public research investments (24) and used as a marker of the technological importance of scientific papers (25) . While it may seem that patents should precede published research, a large study of US patent and paper linkage found that 60% referenced prior research (26) . Patent inclusions have therefore been explored as indicators of papers whose recognition has been delayed. Similarly, a focus on impact assessments has prompted analyses of referencing patterns within cancer guidelines (27) , small hand-curated groups of guidelines (28) , and separately, policy inclusions extracted by hand (29) , systematic analysis of COVID-19 policy(30), or from Altmetric(31) -though difficulties with comprehensive data acquisition have hampered the latter. Although one study has recently attempted to predict combined guideline and clinical trial citations of basic research using a small set of MeSH term derived features (32) , no predictive framework for the tangible product of scientific research, rather than trials, has been previously described. The critique of paper citation metrics for measuring impact is not new, but the argument can now be rigorously tested against objective markers of translation.

The application of highly expressive language models to searchable, comprehensive, fully-digitized repositories of scientific publications has the power to derive compact-yet rich-representations of research activity on which high-fidelity predictive models can be founded. Here focused on the task of predicting translational signals, the approach can be used to forecast many aspects of scientific activity upstream of real-world impact. Our work argues for a radical shift towards the adoption of novel methods in the evaluation of medical research, a shift for which observed levels of translational productivity-declining for more than half a century-demand urgent and decisive action.

The dataset was downloaded from Microsoft Academic Graph (MAG) in March 2019 (17) . It was filtered to include medical papers-as labelled by MAG-published from January 1990 to March 2019, with at least one paper-to-paper citation. To extract a patent inclusion count, papers were matched by id to the reference list on patent entries, in turn provided within MAG through the Lens database (33 The full feature list extracted from MAG is included in Table S2 , and summarily comprised publication year; paper citation count; paper rank; author count; reference count; and rank, paper count and paper citation information for the first and last author, the first and last author's affiliations, the journal and the field. The first level of medical domain fields were extracted-43 in total-and added as features using multiple one hot encoding. Field names from hierarchical topic modelling were supplied within MAG (34) , and rank -a Reinforcement Learning estimation of dynamic eigencentrality, reflecting a paper's connectedness to other influential entries in the graph(35)-was also supplied within MAG. In addition to a simple paper citation count, the number of times a paper was referenced in the text body of another paper was summed to create a 'paper mentions' count.

Predictive analysis NATURAL LANGUAGE PROCESSING. Medical papers were further filtered to include those with titles and abstracts.

Sentence level embeddings were generated for each title using BioBERT (18) , a state-of-the-art BERT language model pre-trained on biomedical corpora comprising PubMed abstracts and PMC full text articles, in addition to general corpora comprising English Wikipedia and BooksCorpus. BERT is a highly influential Transformer encoder, released in 2018, that is able to learn the context of words by joint conditioning on the full sentence, rather than creating a sequential representation where context is lost with increasing distance between words(36). The sentence level embeddings were derived from the output of the first ([CLS]) token.

To create a fixed length abstract level embedding, we truncated the abstracts to 20 sentences or zero padded where the abstract was shorter, replacing each sentence with its BioBERT embedding and concatenating the array to create a 15360-dimensional vector. This was further concatenated with the title vector, creating a 16128-dimensional representation of the title and abstract taken together.

PREPROCESSING. To rebalance the proportions of positive and negative target labels, the majority negative class was randomly sampled without replacement. Papers without a title or abstract were then removed. This led to a 1.1:1 balance of positive to negative labels in the patent group and the guideline or policy group. Data was randomly split into label stratified training and test sets with a 9:1 ratio. Missing values in the metadata were imputed with medians derived from the training split, and values were transformed into z-scores.

MODELLING. To address the primary objective of detecting signals of translation, we trained a series of models to predict a binary outcome of inclusion in a patent vs none, and separately a binary outcome of inclusion in a guideline or policy document vs none. This was motivated by two considerations, first that each outcome was an independent measure of translation rewarding predominantly basic science or clinical science in patent and guideline or policy classes respectively, and second, that patent inclusions were around 50 times more prevalent than guideline or policy inclusions and might unfairly dwarf the predictive signal of the latter class.

We first modelled a single variable-paper citations per year-using logistic regression, to provide a baseline prediction reflecting current citations-based practice. The hyperparameters of this model were optimised using a parallelised, cross-validated gridsearch. Second, we modelled the metadata-all features extracted from MAG pertaining to the paper and its research environment, excluding title and abstract embeddings-using a 6 layer perceptron, with categorial variables one-hot encoded. Third, we trained a 1-dimensional CNN on the title and abstract embeddings, using an initial kernel length and stride of 768 to match the length of each sentence vector. We employed the common architectural heuristics of iteratively decreasing layer sizes and iteratively increasing the number of output channels to a final set of fully connected layers. These two models were tuned by cross-validation within the training set, and the best models were combined into a final model that took both the metadata and title-abstract embeddings as inputs, specified in Fig. S1 . To assess the performance of the final model on future papers, the same architecture was trained from scratch on data from Jan 1990 to Dec 2013, and tested on data from Jan 2014 to Dec 2017. We measured the performance in each of the four years, and within the top 8 fields to investigate the calibration to these groups. To quantify any reliance on time-dependent citation patterns for a given paper, we assessed the performance of the full model whose training set had 'paper citation count', 'paper rank' and 'paper mentions count' variables removed; similarly, to quantify any reliance on features denoting merit extrinsic to the paper, author, institution, journal and field -level ranks and counts were removed.

As further validation, an external, publically available dataset containing the publication output of Nobel Prize

Laureates in Physiology or Medicine(39) was downloaded, matched to MAG, and processed identically to the test data. All papers from 1991-2019 published prior to-and including-the prize-winning paper were tested for patent inclusion prediction using: a logistic regression model of age-normalised-citations; the MLP of extended metadata; and the hybrid model of extended metadata and title-abstract embeddings, each pretrained on the entire training corpus, with the Nobel papers removed. The AUCs and numbers assigned to positive and negative labels were recorded.

As a secondary objective, we sought to understand the correspondence of patent and guideline or policy citations to the far more widely measured and acknowledged paper citations, as well as to understand the community structure of patent included vs non-included groups, and guideline or policy included vs not included groups.

Towards the former aim, we plotted paper citations against translation inclusions, and examined their correlation by fitting a linear regression model with 1000x bootstrapped confidence intervals. We further ranked journals by paper citation counts normalised by the journal's total paper count within our datasetfiltered as described to medical papers from 1990-2019 with at least one citation. This roughly corresponds to a canonical 'Impact Factor', though the interval is widened from yearly to three decades. We repeated this for a journal's patent inclusions count and guideline or policy inclusion count. Journals analysed in this manner were filtered to include only those with 500 or more total papers in the dataset.

Towards the latter aim, we fit Bayesian weighted, non-parametric, nested stochastic block models (19) on all papers with patent inclusions, and all papers without them, and then again on all papers with guideline or policy inclusions, and all papers without them, degree-corrected and weighted exponentially by the absolute value of the pairwise correlations of features extracted from MAG (excluding titles and abstracts). Stochastic block models are generative random graph models which display community structures, subsets of nodes connected by larger edge densities than those outside the subset. The models were strengthened by sampling from the posterior distribution and equilibrated with Markov Chain Monte Carlo over 100,000 iterations to ensure convergence. Scalable force directed placement (40) was used for visualisation of the combined feature graph, with node size proportional to eigencentrality, and edge weight and colour proportional to the absolute value of the correlation coefficient between two features.

ANALYTIC ENVIRONMENT. All analyses were written in Python 3.5. Preprocessing was performed using

Pandas (41), NumPy (42) and Scikit-Learn (43) , and visualisation using Matplotlib (44) , Seaborn (45), Graphtool (46) . Neural networks were built in Keras (47) 

Bibliometrics and Citation Analysis: From the Science Citation Index to Cybermetrics

A Unified Index to Science

Little science, big science--and beyond

Conform and be funded

Bibliometric indicators to assist the peer review process in grant decisions

How has healthcare research performance been assessed?: a systematic review

Two h-Index Benchmarks for Evaluating the Publication Performance of Medical Informatics Researchers

The electronic Scientific Portfolio Assistant: Integrating scientific knowledge databases to support program impact assessment

Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation

The measure of research merit

Superconductivity, what the H? The emperor has no clothes

Redefining the research hospital

Translation of highly promising basic science research into clinical applications

Cutting random funding decisions

The acceptability of using a lottery to allocate research funding: a survey of applicants

Mavericks and lotteries

MAS) and Applications in Proceedings of the 24th International Conference on World Wide Web, WWW '15 Companion

BioBERT: a pre-trained biomedical language representation model for biomedical text mining

Hierarchical Block Structures and High-Resolution Model Selection in Large Networks

Learning on knowledge graph dynamics provides an early warning of impactful research

Predicting scientific success

Using content-based and bibliometric features for machine learning models to predict citation counts in the biomedical literature

Exploring Characteristics of Patent-Paper Citations and Development of New Indicators

The applied value of public investments in biomedical research

Patent Citations Analysis and Its Value in Research Evaluation: A Review and a New Approach to Map Technology-relevant Research

The dual frontier: Patented inventions and prior scientific advance

The impact of cancer research: how publications influence UK cancer clinical guidelines

Evaluating "payback" on biomedical research from papers cited in clinical guidelines: applied bibliometric study

Does citation matter? Research citation in policy documents as an indicator of research impact -an Australian obesity policy case-study

Coevolution of policy and science during the pandemic

How many scientific papers are mentioned in policy-related documents? An empirical investigation using Web of Science and Altmetric data

Predicting translational progress in biomedical research

Mapping the global influence of published research on industry and innovation

A Web-scale system for scientific knowledge exploration

Pre-training of Deep Bidirectional Transformers for Language Understanding

A Decision-Theoretic Generalization of On-Line Learning and an Application to Boosting

Visualizing Data using t-SNE

A dataset of publication records for Nobel laureates

Efficient, High-Quality Force-Directed Graph Drawing

Data Structures for Statistical Computing in Python in (2010)

Python for Scientific Computing

Scikit-learn: Machine Learning in Python

Matplotlib: A 2D Graphics Environment

The graph-tool python library

Automatic differentiation in PyTorch

) for the hybrid CNN and MLP model trained on data from 1990 to 2013, and tested on papers published in the subsequent 4 years, plotted by year, for guideline or policy inclusions and patent inclusions respectively. ROC curves (E, G), and Precision-Recall curves (F, H) for combination CNN and MLP model trained on data from 1990-2013, and tested on data from

Stochastic Neighbour Embedding (t-SNE) projection in 2-dimensions of title and abstract BioBERT autoencoder embeddings. Labelled by the presence (orange) or absence (blue) of a guideline or policy (A) or patent (B) inclusion. Note discernible data structure that enables accurate prediction of inclusion

The authors declare that they have no competing interests.

The data that support the findings of this study are available on application to Microsoft Academic Graph at https://www.microsoft.com/en-us/research/project/microsoft-academic-graph/. Guideline and policy data are available from the Reach project at Wellcome Data Labs https://reach.wellcomedatalabs.org/. Code for extracting guideline and policy references is available at https://github.com/wellcometrust/reach. Analytic code will be made available upon reasonable request.